Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business UpdateGlobeNewsWire • 08/10/26
Countdown to Axsome (AXSM) Q2 Earnings: Wall Street Forecasts for Key MetricsZacks Investment Research • 08/05/26
Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 08/03/26
Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in NarcolepsyGlobeNewsWire • 07/15/26
Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10GlobeNewsWire • 07/14/26
Axsome Begins Phase III Study on Solriamfetol for ADHD in ChildrenZacks Investment Research • 07/08/26
Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)GlobeNewsWire • 07/07/26
These 3 Stocks Trounced the S&P 500 in the First Half of 2026 -- and Wall Street Thinks 1 of Them Could Soar Even MoreThe Motley Fool • 07/06/26
Is Axsome Therapeutics Stock a Millionaire Maker? Here's What the Numbers Say.The Motley Fool • 07/02/26
Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)GlobeNewsWire • 06/26/26
Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness MonthGlobeNewsWire • 06/18/26
Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026GlobeNewsWire • 06/15/26
Axsome Therapeutics, Inc. (AXSM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/08/26
Axsome Therapeutics Readies Auvelity Alzheimer's Agitation Launch, Expands CNS PipelineMarketBeat • 06/06/26
Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific MeetingGlobeNewsWire • 06/04/26
Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent LitigationGlobeNewsWire • 06/03/26